Your browser doesn't support javascript.
Changes in Alcohol-Related Behaviors and Quality of Life During the COVID-19 Pandemic: Impact of Alcohol Use Disorder Diagnosis and Treatment History.
Luk, Jeremy W; Stangl, Bethany L; Gunawan, Tommy; Schwandt, Melanie L; Morris, James K; Axelowitz, Jared C; Chawla, Sumedha; Lee, Beth A; Carraco, Megan; Walsh, Sheila; McDuffie, Christian; Agarwal, Khushbu; Joseph, Paule V; Momenan, Reza; Goldman, David; Diazgranados, Nancy; Ramchandani, Vijay A.
  • Luk JW; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Stangl BL; Corresponding authors: Jeremy W. Luk, PhD, National Institute on Alcohol Abuse and Alcoholism (NIAAA), Office of the Clinical Director, Bldg 10 - CRC, Room 1-5340, Bethesda, MD 20892 (jeremy.luk@nih.gov); Vijay A. Ramchandani, PhD, National Institute on Alcohol Abuse and Alcoholism (NIAAA), Human Ps
  • Gunawan T; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Schwandt ML; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Morris JK; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Axelowitz JC; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Chawla S; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Lee BA; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Carraco M; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Walsh S; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • McDuffie C; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Agarwal K; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Joseph PV; Section of Sensory Science and Metabolism, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Momenan R; Section of Sensory Science and Metabolism, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Goldman D; Section of Sensory Science and Metabolism, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Diazgranados N; Clinical NeuroImaging Research Core, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Ramchandani VA; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
J Clin Psychiatry ; 84(1)2022 11 07.
Article in English | MEDLINE | ID: covidwho-2269915
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Alcoholism / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Alcoholism / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Year: 2022 Document Type: Article